Highlights
NASDAQ: ONCE       Spark Therap Cmn
Last Price Today's Change   Day's Range   Trading Volume
72.68   +1.86 (2.63%)  70.52 - 73.74  243,461

Overview

 
Avg Volume (4 weeks):440,597
4 Weeks Range:57.00 - 74.29
4 Weeks Price Volatility (%):
90.69%
52 Weeks Range:35.07 - 74.29
52 Weeks Price Volatility (%):
95.89%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.

  Be the first to like this.
 


 

3351  3825  595  654 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 14.76+0.65 
 T 38.03+1.81 
 F 11.06-0.21 
 BAC 24.21-0.27 
 GDX 22.85+0.58 
 DCTH 0.136-0.011 
 AKS 6.24-0.54 
 XLF 25.05-0.17 
 X 26.20+1.76 
 EEM 44.01+0.36 
Partners & Brokers